Evidence map›Paper›PMID 16154907›Full record

ArticleMolecular membrane biology

Regulation of expression and function of Lck tyrosine kinase by high cell density.

Patricia Ozegbe, Yuti Chernajovsky, Panagiotis S Kabouridis

Open access · greenAbstract read
In one paragraph

Article in Molecular membrane biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Patricia OzegbeBone & Joint Research Unit, William Harvey Research Institute, Queen Mary's School of Medicine & Dentistry, University of London, London, UK.
Yuti Chernajovsky
Panagiotis S Kabouridis
University of London · GBWilliam Harvey Research Institute · GB

Funding

Wellcome Trust 058408
6 · The paper itself

Abstract

For many types of cells, an increase in cell density leads to characteristic changes in intracellular signalling and cell function. It is unknown, however, whether cell density affects the function of T lymphocytes. It is presented here that aggregation of Jurkat T cells, murine thymocytes or human peripheral blood T cells, results in gradual modification of the Lck tyrosine kinase. Within one hour of aggregation, Lck in the detergent-insoluble lipid raft fraction is dephosphorylated mainly at the carboxy-terminal tyrosine. Further aggregation leads to gradual loss of Lck protein from both lipid raft and non-raft fractions which is accompanied by increased protein ubiquitination, a process that is more evident in the detergent-soluble fraction. In contrast, the expression of LAT, which like Lck distributes to raft and non-raft membrane, or Csk, a kinase with a structure similar to Lck, is not affected by cell aggregation. Dephosphorylation of lipid raft-associated Lck, albeit with reduced kinetics, is observed in aggregated Jurkat CD45-deficient cells as well, suggesting involvement of additional tyrosine phosphatases. Changes in Lck structure and expression correlate with reduced ability of aggregated cells to fully activate protein tyrosine phosphorylation after stimulation of the TCR, and with changes in the activation of down-stream signalling cascades.

Indexed as

AnimalsApoptosisCell AggregationGene Expression RegulationHumansJurkat CellsKineticsLeukocyte Common AntigensLymphocyte CountLymphocyte Specific Protein Tyrosine Kinase p56(lck)Membrane MicrodomainsMiceMice, Inbred DBAPhosphorylationReceptors, Antigen, T-CellSignal TransductionLeukocyte Common AntigensLymphocyte Specific Protein Tyrosine Kinase p56(lck)Receptors, Antigen, T-CellTyrosineUbiquitin

Identifiers

PMID16154907
PMCPMC2596299
OpenAlexW2166857939

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.